via www.cumc.columbia.edu
A revolutionary technique that promises to restore the sight of millions has been carried out for the first time worldwide in a British hospital.
Taking as little as 45 minutes, the procedure offers hope to those with age-related macular degeneration, the leading cause of blindness in adults globally.
It affects more than 600,000 adults in the UK, blighting the lives of a quarter of the over-60s.
In the breakthrough developed at University College London, doctors inserted a patch of stem cells into the retina of a woman who has lost her central vision.
They hope the procedure, carried out at Moorfields Eye Hospital in the capital, will restore the 60-year-old’s sight but will not know the outcome until December.
However, doctors said she suffered no complications and her eye is recovering well from the procedure.
This first operation has begun a clinical trial involving ten patients. If successful, the technique could be available on the NHS within two-and-a-half years.
The procedure, which has attracted the support of medical giant Pfizer, is carried out under local anaesthetic. It involves taking a single embryonic stem cell and growing it into a 6mm patch of 100,000 retinal pigment cells.
That patch is then rolled into a thin tube, which is injected through a tiny slit in the eye.
Once unfurled, it is placed behind the retina where scientists hope it will replace the faulty cells.
The operation is a milestone in the London Project to Cure Blindness established ten years ago with the aim of curing vision loss in patients with age-related macular degeneration.
The first step has been carried out on the wet form of the condition when a patient bleeds at the back of the eye. But scientists are confident it could also be used for the more common dry AMD, which affects 85 per cent of British sufferers.
The Latest on: Age-related macular degeneration
via Google News
The Latest on: Age-related macular degeneration
- Springer Honoree explores age-related macular degeneration at annual lectureon May 22, 2022 at 10:44 pm
Age-related macular degeneration was the topic at the UAB School of Optometry’s annual Springer Lecture, presented by the 2017 Springer Award Honoree, Christine Curcio, Ph.D., professor at the UAB ...
- Macular Degeneration and the Age-related Eye Disease Studyon May 20, 2022 at 5:00 pm
macula displacement; wavy appearance to straight lines Recommended if in one eye only AMD: age-related macular degeneration. Source: References 5, 26.
- Dried goji berries may provide protection against age-related vision losson May 20, 2022 at 6:36 am
Regularly eating a small serving of dried goji berries may provide protection against age-related macular degeneration, the leading cause of vision loss in seniors. The researchers found that 13 ...
- What to know about OCT for macular degenerationon May 19, 2022 at 10:22 am
Damage to the macula can lead to age-related macular degeneration (AMD), an eye disease causing loss of central vision. Doctors may use OCT to help them diagnose AMD and monitor treatment progress.
- Arizona surgeon first to administer new gene therapy to combat macular degenerationon May 18, 2022 at 4:14 pm
Dr. Mark Barakat is the first surgeon in the state to administer the new gene therapy for people who suffer from the disease.
- Age-Related Macular Degeneration Market Size, Opportunities, Trends, Products, Revenue Analysis Till 2027on May 17, 2022 at 5:49 am
The age-related macular degeneration market is soaring higher all across the globe in recent times. So, the market value is predicted to reach USD 11.18 billion during the forecast period. Over the ...
- Wet Age-Related Macular Degeneration Market to flourish with a 4.5% CAGR and has a Promising Outlook with Emerging Therapies, Estimates DelveInsighton May 16, 2022 at 4:00 pm
Market” report provides a thorough comprehension of the Wet Age-Related Macular Degeneration, historical and forecasted epidemiology, and the wet AMD market trends in the 7MM [the United States, EU5 ...
- Age-Related Macular Degeneration Treatment Market Is Predicted To Witness Healthy Growthon May 16, 2022 at 12:49 am
Age-Related Macular Degeneration Treatment Market NEW YORK, NY, U.S., May 15, 2022 /EINPresswire.com / -- A report was released recently ...
- Age Related Macular Degeneration Drug Market Size, Share, Statistics, Demand and Revenue, Forecast 2025on May 2, 2022 at 7:05 am
May 02, 2022 (Market Insight Reports) -- Global Age Related Macular Degeneration Drug Market Report focuses on the major drivers and restraints for the key players. These Research Report also ...
- Myopic Macular Degeneration: What You Should Know About Pathological Myopiaon May 1, 2022 at 5:01 pm
While this condition is similar to age-related macular degeneration (AMD) in some ways, they are not the same. The two conditions share many of the same symptoms and can cause vision decline.
via Bing News
